Fortitude's Strong Q2 and $1M Stake in HeartSciences at a 22% Premium
HSCS sits 55% above its 52-week low of $1.63 on light trading volume (0.1× avg).
Summary
Fortitude Mining reported strong Q2 results and invested $1 million in HeartSciences at a 22% premium, reinforcing its commitment to the pending merger.
Key Events · M&A and Partnerships · HSCS
-
Fortitude Q2 Financials
Fortitude reported Q2 2026 revenue of $20.9 million and Adjusted EBITDA of $8.5 million, with 33,646 ZEC mined at an average hash rate of 4.0 GSol/s.
-
Private Placement Investment
Fortitude purchased 411,522 shares of HeartSciences common stock for approximately $1.0 million at $2.43 per share, a 22% premium to the August 12 closing price.
-
Ownership Stake
Following the subscription, Fortitude owns approximately 9.4% of HeartSciences' outstanding common stock, with no additional rights or preferences.
-
Merger Terms Unchanged
The exchange ratio under the merger agreement remains unchanged, and Fortitude will not receive additional shares at closing as a result of the subscription.
Analysis · HSCS · Crypto Assets
Fortitude Mining, the merger partner of HeartSciences, disclosed Q2 revenue of $20.9 million and Adjusted EBITDA of $8.5 million, demonstrating the operating strength of the business HeartSciences shareholders are being asked to acquire. More importantly, Fortitude purchased $1 million of HeartSciences stock at $2.43 per share — a 22% premium to the market price — signaling strong commitment to closing the deal and providing near-term operating capital. This investment gives Fortitude a 9.4% stake and does not alter the merger exchange ratio, so existing shareholders are not further diluted by this transaction. The filing comes amid HeartSciences' going-concern warning and Nasdaq delisting notice, making this capital infusion and vote of confidence a critical development for the pending merger.
At the time of this filing, HSCS was trading at $2.52 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $9.9M. The 52-week trading range was $1.63 to $3.93. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.